Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IGC Pharma (IGC) Shares Outstanding (2016 - 2025)

IGC Pharma (IGC) has disclosed Shares Outstanding for 15 consecutive years, with $92.0 million as the latest value for Q3 2025.

  • Quarterly Shares Outstanding rose 19.99% to $92.0 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $92.0 million through Sep 2025, up 19.99% year-over-year, with the annual reading at $80.9 million for FY2025, 21.27% up from the prior year.
  • Shares Outstanding for Q3 2025 was $92.0 million at IGC Pharma, up from $84.1 million in the prior quarter.
  • The five-year high for Shares Outstanding was $92.0 million in Q3 2025, with the low at $47.8 million in Q1 2021.
  • Average Shares Outstanding over 5 years is $62.9 million, with a median of $53.1 million recorded in 2022.
  • The sharpest move saw Shares Outstanding rose 2.38% in 2023, then skyrocketed 42.5% in 2024.
  • Over 5 years, Shares Outstanding stood at $51.1 million in 2021, then increased by 3.96% to $53.1 million in 2022, then increased by 20.08% to $63.7 million in 2023, then rose by 22.7% to $78.2 million in 2024, then increased by 17.59% to $92.0 million in 2025.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $92.0 million, $84.1 million, and $80.9 million for Q3 2025, Q2 2025, and Q1 2025 respectively.